Wednesday, November 6, 2024
HomeTagsRead Magazine

Read Magazine

AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101

AnBogen Therapeutics, a clinical-stage biotech company designing and developing precision oncology therapies to improve the life of patients, announces that U.S. Food and Drug...

Regen BioPharma, Inc. Begins Experiments Validating Its Proprietary CAR-T Cell Therapy

Regen BioPharma, Inc. announced initiation of a series of phased experiments to begin the process of moving its CAR-T cell de-differentiation approach through pre-clinical...

Popularity of Home Security, Live Video Monitoring Prevents Crime per ASC Security

As recently as 2020, it was estimated that 63 percent of U.S. households want smart locks and alarms in their homes. Additionally, more than...

Food Forest Abundance Announces New Way to Grow Food for Entire Communities

Food Forest Abundance, with operations in 12 countries and 35 states, announced the creation of their new Freedom Farm Academies. This comes at a...

Pasturebird Unveils New Packaging and Launches Into Retail at 2022 Natural Products Expo

Pasturebird, a company on a mission to revolutionize agriculture by applying modern technology to ancient farming methods and make pasture raised poultry more accessible...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics